Astellas Pharma (4503.T) Market Cap

Price: $1477.5
Market Cap: $2.64T
Avg Volume: 6.30M
Country: JP
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.157
52W Range: $1415-1835
Website: Astellas Pharma

Market Cap Overview

Market Cap

$2.64T

Share Price

$1477.5

Shares Outstanding

1.79B


What is Astellas Pharma's Market Cap?

Astellas Pharma's current Market Cap as of today is $2.64T.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Astellas Pharma, the market cap is calculated as $1477.5 x 1.79B shares = $2.64T.

As a Mega Cap company, Astellas Pharma is among the largest companies in the world.

Astellas Pharma Historical Market Cap

$4.40T$4.40T$4.00T$4.00T$3.60T$3.60T$3.20T$3.20T$2.80T$2.80T$2.40T$2.40TMarket CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Astellas Pharma Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Astellas Pharma, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$5.00T$5.00T$4.00T$4.00T$3.00T$3.00T$2.00T$2.00T$1.00T$1.00T$0.00$0.00ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Astellas Pharma's enterprise value as of December 31, 2024 (Q3 2024) is calculated as:

  • Market Cap: $2.64T
  • Total Debt: $915.36B
  • Cash and Equivalents: $179.87B
  • Enterprise Value: $3.48T

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Astellas Pharma Annual Market Cap History

Year Market Cap Change
2025 $2.64T -10.12%
2023 $2.94T -14.13%
2022 $3.43T -3.05%
2021 $3.53T 11.83%
2020 $3.16T 0.82%
2019 $3.14T -4.23%
2018 $3.27T -0.10%
2017 $3.28T 5.97%
2016 $3.09T -4.26%
2015 $3.23T -25.69%
2014 $4.35T 58.07%
2013 $2.75T 21.14%
2012 $2.27T 44.56%
2011 $1.57T 10.39%
2010 $1.42T -9.01%
2009 $1.56T 12.09%
2008 $1.39T -21.76%
2007 $1.78T -24.02%
2006 $2.35T 13.65%
2005 $2.06T 23.14%
2004 $1.68T 1.40%
2003 $1.65T N/A

Frequently Asked Questions

Astellas Pharma's current market capitalization is $2.64T. This makes it a Mega Cap company, calculated by multiplying its current stock price of $1477.5 by 1.79B outstanding shares.

Astellas Pharma's enterprise value is $3.48T. This is calculated by adding total debt ($915.36B) to market cap and subtracting cash and equivalents ($179.87B). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Astellas Pharma has 1.79B shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Astellas Pharma is classified as a Mega Cap company. Mega-cap companies are the largest publicly traded companies with market caps exceeding $200 billion.

Astellas Pharma's market cap is calculated by multiplying its current stock price ($1477.5) by its total number of outstanding shares (1.79B). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for 4503.T.